97 related articles for article (PubMed ID: 10604136)
21. Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Forrer F; Valkema R; Kwekkeboom DJ; de Jong M; Krenning EP
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):111-29. PubMed ID: 17382268
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease.
Höcker M; Wiedenmann B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S139-42. PubMed ID: 10604118
[TBL] [Abstract][Full Text] [Related]
23. Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours.
Bodei L; Cremonesi M; Grana C; Rocca P; Bartolomei M; Chinol M; Paganelli G
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1038-46. PubMed ID: 15150675
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
Lewis JS; Lewis MR; Cutler PD; Srinivasan A; Schmidt MA; Schwarz SW; Morris MM; Miller JP; Anderson CJ
Clin Cancer Res; 1999 Nov; 5(11):3608-16. PubMed ID: 10589778
[TBL] [Abstract][Full Text] [Related]
25. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.
Kölby L; Bernhardt P; Johanson V; Schmitt A; Ahlman H; Forssell-Aronsson E; Mäcke H; Nilsson O
Br J Cancer; 2005 Nov; 93(10):1144-51. PubMed ID: 16251870
[TBL] [Abstract][Full Text] [Related]
26. [Yttrium 90 DOTATOC: a new somatostatin analog for cancer therapy of neuroendocrine tumors].
Otte A; Herrmann R; Mäcke HR; Müller-Brand J
Praxis (Bern 1994); 1999 Aug; 88(31-32):1263-8. PubMed ID: 10479965
[TBL] [Abstract][Full Text] [Related]
27. Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogue.
Waldherr C; Haldemann A; Maecke HR; Crazzolara A; Mueller-Brand J
Clin Oncol (R Coll Radiol); 2000; 12(2):121-3. PubMed ID: 10853753
[TBL] [Abstract][Full Text] [Related]
28. [Somatostatin receptors in meningioma: diagnostic and therapeutic value].
Prat R; Banzo J; Díaz FJ
Rev Neurol; 1997 Dec; 25(148):2002-5. PubMed ID: 9528047
[TBL] [Abstract][Full Text] [Related]
29. Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man.
Albert R; Smith-Jones P; Stolz B; Simeon C; Knecht H; Bruns C; Pless J
Bioorg Med Chem Lett; 1998 May; 8(10):1207-10. PubMed ID: 9871736
[TBL] [Abstract][Full Text] [Related]
30. "MAURITIUS": tumour dose in patients with advanced carcinoma.
Virgolini I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Smith-Jones P
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S227-30. PubMed ID: 10604137
[TBL] [Abstract][Full Text] [Related]
31. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide.
Krenning EP; Valkema R; Kooij PP; Breeman WA; Bakker WH; deHerder WW; vanEijck CH; Kwekkeboom DJ; deJong M; Pauwels S
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S219-23. PubMed ID: 10604135
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
[TBL] [Abstract][Full Text] [Related]
33. OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.
Smith MC; Liu J; Chen T; Schran H; Yeh CM; Jamar F; Valkema R; Bakker W; Kvols L; Krenning E; Pauwels S
Digestion; 2000; 62 Suppl 1():69-72. PubMed ID: 10940690
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptors: clinical implications for endocrinology and oncology.
Lamberts SW; de Herder WW; van Koetsveld PM; Koper JW; van der Lely AJ; Visser-Wisselaar HA; Hofland LJ
Ciba Found Symp; 1995; 190():222-36; discussion 236-9. PubMed ID: 7587649
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study.
Marincek N; Jörg AC; Brunner P; Schindler C; Koller MT; Rochlitz C; Müller-Brand J; Maecke HR; Briel M; Walter MA
J Transl Med; 2013 Jan; 11():17. PubMed ID: 23320604
[TBL] [Abstract][Full Text] [Related]
36. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
[TBL] [Abstract][Full Text] [Related]
37. In vivo molecular imaging of somatostatin receptors in pancreatic islet cells and neuroendocrine tumors by miniaturized confocal laser-scanning fluorescence microscopy.
Fottner C; Mettler E; Goetz M; Schirrmacher E; Anlauf M; Strand D; Schirrmacher R; Klöppel G; Delaney P; Schreckenberger M; Galle PR; Neurath MF; Kiesslich R; Weber MM
Endocrinology; 2010 May; 151(5):2179-88. PubMed ID: 20233796
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors.
Bushnell D; O'Dorisio T; Menda Y; Carlisle T; Zehr P; Connolly M; Karwal M; Miller S; Parker S; Bouterfa H
J Nucl Med; 2003 Oct; 44(10):1556-60. PubMed ID: 14530466
[TBL] [Abstract][Full Text] [Related]
39. (2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice.
Guhlke S; Wester HJ; Bruns C; Stöcklin G
Nucl Med Biol; 1994 Aug; 21(6):819-25. PubMed ID: 9234331
[TBL] [Abstract][Full Text] [Related]
40. [Somatostatin receptors. A new way to diagnosis and therapy of neuroendocrine tumors].
Wängberg B; Nilsson O; Wigander A; Johansson V; Forssell-Aronsson E; Andersson P; Fjälling M; Tisell LE; Ahlman H
Lakartidningen; 1997 Mar; 94(10):829-30, 835-8. PubMed ID: 9102509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]